What is the Buying Price of Aarti Drugs Share?

The Buying Price of Aarti Drugs share is 367.75 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Aarti Drugs Share at Choice?

To buy Aarti Drugs stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarti Drugs, choose your preferred order type, and place the trade.

What is the PE ratio of Aarti Drugs Shares?

The Price-to-earnings (P/E) ratio of Aarti Drugs shares is 16.57. You can compare it with the sector average for relative valuation.

What is the PB ratio of Aarti Drugs Shares?

The Price to Book (P/B) ratio Aarti Drugs shares is 2.23. Useful to assess the stock's value relative to its book value.

Is Aarti Drugs Overvalued?

To assess Aarti Drugs’s valuation compare Sector P/E, P/B which are 71.32 & 3.47 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Aarti Drugs?

The Market Cap of Aarti Drugs is 3356.45 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Aarti Drugs Share Price?

The 52 week high and low prices of Aarti Drugs share price is 564.05 & 318.95. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Aarti Drugs belong to?

Aarti Drugs belongs to the Healthcare sector.

Aarti Drugs Share price

AARTIDRUGS

Healthcare Mid Cap

367.75

5.40 (1.49%)

NSE

BSE

Last updated on 15 May, 2026 | 15:51 IST

BUYSELL

Today's High

374.80

Today's Low

360.00

52 Week Low

318.95

52 Week High

564.05

Free Demat with Zero AMC*

Aarti Drugs Chart

ChartIQ

TradingView

Aarti Drugs Share Key Metrics

Volume

2.07 L

Market Cap

3356.45 CR

LTQ@LTP

13@367.75

ATP

367.88 Var Margin

18.36 %

Circuit Range

289.9-434.8

Delivery %

49.06 %

Value

7.62 CR

ASM/GSM

No

Market Lot

1

Summary

15 May, 2026 | 15:51 को, Aarti Drugs का शेयर प्राइस आज ₹367.75 पर है, जो दिन के लिए 5.40% की 1.49 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹360.00 और ₹374.80 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹318.95 से ₹564.05 तक रही है। ट्रेडिंग गतिविधि के मामले में, Aarti Drugs ने 207078 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹91270000 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹36788 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 13,36775 रही। यह स्टॉक ₹289.9-434.8 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹7.62 CR है। दिन के लिए डिलीवरी परसेंटेज 49.06% रही। इसके अतिरिक्त, Aarti Drugs वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Aarti Drugs Fundamentals

P/E Ratio

16.57

P/B Ratio

2.23

Div. Yield

0.27

Sector P/E

71.32

Sector P/B

3.47

Sec. Div. Yield

0.56

Aarti Drugs Resistance and Support

Pivot 365.62

Resistance

First Resistance

372.64

Second Resistance

382.92

Third Resistance

389.94

Support

First Support

355.34

Second Support

348.32

Third Support

338.04

Aarti Drugs Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

55.03%

Mutual Fund

10.14%

Insurance

0.08%

Foreign Institutional Investors

1.57%

Domestic Institutional Investors

0.01%

Retail

33.18%

Others

-0.01%

Total Promoters

MAR '26

55.03%

Aarti Drugs Corporate Actions

Date	Agenda
2026-05-15	Audited Results
2026-02-03	Quarterly Results & Interim Dividend

Aarti Drugs News

Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Aarti Drugs reported Q4 FY26 revenue of Rs.721.1 cr, up 6% YoY, and net profit of Rs.55.3 cr, down 12% YoY. For the full FY26, revenue grew 7% YoY to Rs.2,567.7 cr, with net profit rising 16% YoY to Rs.194.9 cr, driven by sequential recovery in Q4.

May 16 2026 14:05:00

Q4 Results LIVE Updates: Premier Energies profit up 64%; Power Grid beats profit estimates

Aarti Drugs is scheduled to announce its financial results for the fourth quarter of fiscal year 2026 on May 15, 2026, as part of a broader earnings season where numerous companies are declaring their Q4 results.

May 15 2026 20:05:00

Aarti Drugs Q4 profit falls 12% despite revenue growth

Aarti Drugs reported its Q4 results, showing a 12% decline in net profit despite a 9% increase in revenue. The company's financial performance for the quarter indicates pressure on profitability.

May 15 2026 19:05:00

Aarti Drugs Ltd - 524348 - Re-Appointment Of Cost Auditor And Internal Auditor

Aarti Drugs board held a meeting on May 15, 2026, approving the audited standalone and consolidated financial results for Q4 & FY26. The board also re-appointed M/s GMVP & Associates LLP as Cost Auditor and M/s Raman S. Shah & Co. as Internal Auditor for FY27. Additionally, the Risk Management Committee was re-constituted with a new Non-Executive Director.

May 15 2026 18:05:00

Q4 Results LIVE Updates: Gland Pharma profit up 97%; Ratnamani Metals margin slips

Aarti Drugs Limited's Board of Directors is scheduled to convene today, May 15, 2026, to consider and approve the company's financial results for the fourth quarter of fiscal year 2026. This comes as numerous other companies are also reporting their Q4FY26 earnings today. [2, 10]

May 15 2026 16:05:00

Q4 Results LIVE Updates: Hindustan Copper revenue jumps 58%; ITC Hotels profit up 23%

Aarti Drugs Limited is scheduled to hold a Board Meeting today, May 15, 2026, to consider and approve its financial results for the fourth quarter of fiscal year 2026.

May 15 2026 16:05:00

Q4 Results LIVE Updates: ITC Hotels profit up 23%; Alembic Pharma margin slips

Aarti Drugs is scheduled to announce its financial results for the fourth quarter of fiscal year 2026 today, May 15, 2026, as part of the ongoing earnings season.

May 15 2026 15:05:00

Q4 Results LIVE Updates: Alembic Pharma margin slips; SJVN revenue nearly triples

Aarti Drugs is scheduled to announce its Fourth Quarter FY26 financial results today, May 15, 2026, as listed in this live blog covering corporate earnings.

May 15 2026 14:05:00

Q4 Results LIVE Updates: HUDCO expects 3% NIMs next quarter; Tata Steel earnings awaited

Aarti Drugs is scheduled to announce its financial results for the fourth quarter of fiscal year 2026 on May 15, 2026.

May 15 2026 11:05:00

Q4 Results LIVE Updates: Sai Life Sciences down 12%; Tata Steel, Power Grid report today

Aarti Drugs Limited's Q4 FY26 financial results have been announced, and the company has scheduled an earnings conference call for May 18, 2026, where senior management will discuss the quarter's performance and future outlook. [2, 3, 4, 5]

May 15 2026 09:05:00

NSE : 4481

BSE : 524348

ISIN : INE767A01016

Aarti Drugs Management

Name	Position
Rushikesh Deole	Company Secretary & Compliance Officer
Chandrakant V Gogri	Chairman Emeritus

Aarti Drugs Similar Stocks

Advanced Enzyme Technologies Ltd.

363.75

-1.50 (0.41%)

RPG Life Sciences Ltd.

2292.50

-55.90 (2.38%)

SMS Pharmaceuticals Ltd.

400.40

0.90 (0.23%)

Indraprastha Medical Corporation Ltd.

367.75

-10.80 (2.85%)

Orchid Pharma Ltd.

712.60

-6.65 (0.92%)

Gujarat Themis Biosyn Ltd.

370.30

-2.70 (0.72%)

IOL Chemicals And Pharmaceuticals Ltd.

105.94

-3.41 (3.12%)

Bliss GVS Pharma Ltd.

277.65

-11.75 (4.06%)

Gufic Biosciences Ltd.

282.00

-4.50 (1.57%)

Dishman Carbogen Amcis Ltd.

194.25

16.62 (9.36%)

Aarti Drugs FAQs

Aarti Drugs शेयर का खरीद मूल्य 367.75 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Aarti Drugs शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Aarti Drugs शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 16.57 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Aarti Drugs शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.23 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Aarti Drugs शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.47 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Aarti Drugs का मार्केट कैप 3356.45 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Aarti Drugs शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 564.05 और 318.95 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।